TEZSPIRE is an add-on maintenance treatment for people aged 12 and older with severe asthma. TEZSPIRE is not a rescue medication.

Administration and Dosage:

• Administer by subcutaneous injection.
• Recommended dosage is 210 mg administered once every 4 weeks.


TEZSPIRE is a thymic stromal lymphopoietin (TSLP) blocker, human monoclonal antibody (IgG2λ), indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.

Common Side Effects:

The most common side effects of TEZSPIRE include: Sore throat, joint and back pain. These are not all the possible side effects.

More information:

Please see full Prescribing Information including Patient Information.


We are happy to help!